Medscape Review Supports Effectiveness And Safety Of New Non-drug Blood Pressure Treatment (Medical News Today)
InterCure, Ltd., today announced the publication of a peer-reviewed clinical overview of seven clinical trials evaluating the efficacy of device-guided breathing. The study's authors conclude that RESPeRATE, an FDA-cleared over-the-counter therapeutic device, is an effective non-pharmacologic treatment option for treating hypertension with no side effects. [click link for full article]

Claris bets big on injectables, aims Rs.1000 cr sales in 2 years (PharmaBiz)
The Ahmedabad based drug manufacturer Claris Life Sciences bets big on injectables manufacturing with focus on creating brand equity around the global markets and focus on semi regulated markets as the route to emerge as a major drug maker from India.